AFRM · Affirm Holdings, Inc.

The thesis

Affirm's operating case is intact but the shares have not followed it: fiscal 2027 guidance and a wave of higher analyst targets sit against a close of $70.43 on 1 October 2026, and the next quarterly report (about 5 November 2026, est.) decides whether revenue confirms the guidance. The narrative is saturated: the target-raising sequence that followed the 27 August 2026 report has not produced a higher price, and the shares closed 17.9% below the $85.78 52-week high (split- and dividend-adjusted series).

The company reported fourth-quarter fiscal 2026 gross merchandise volume (GMV, the dollar value of purchases financed on its platform) of $14.1 billion and revenue of $1.17 billion on 27 August 2026. Management guided fiscal 2027 GMV above $64 billion and adjusted operating margin above 30.5%. Affirm's fiscal year ends 30 June, so the quarter that ended 30 September 2026 is the first one measured against that guidance.

The reference close of $70.43 sits 2.1% above the $69 weekly-close level that the prior note tied to the reclaimed 200-day moving average. The 14-day relative strength index (RSI) was 47.7 on 1 October 2026, a neutral reading. The shares are rate-sensitive: Benzinga reported on 28 August 2026 that Federal Reserve Chair Kevin Warsh's inflation comments lifted odds of a September rate hike to 60%.

Bullish and bearish views on Affirm Holdings, Inc.

The bull case on Affirm Holdings, Inc. (AFRM), in brief: Reported growth beat expectations. The bear case: Price has not confirmed the upgrades.

Bull case

• Reported growth beat expectations. On 27 August 2026 Affirm reported GMV up 36% year over year to $14.1 billion against $13.39 billion consensus, and revenue up 33% to $1.17 billion against $1.11 billion consensus.
• Profit grew with volume. The same report showed $147 million of operating income under generally accepted accounting principles (GAAP), a 12.6% margin, and $353 million of adjusted operating income. The fiscal 2027 adjusted margin guide of more than 30.5% is the number to test.
• Credit measure improved in its defined scope. The 27 August 2026 earnings supplement reported 30-day delinquency of 2.5% on monthly installment loans excluding Peloton and Pay-in-X, against 2.7% to 2.8% in preceding quarters. It does not cover the whole book.
• Analysts raised targets broadly. After the report, Goldman Sachs raised its target to $115 and Bernstein to $110 (both 31 August 2026), TD Cowen to $124 (28 August 2026), and Scotiabank initiated with a $95 target and Sector Outperform rating (2 September 2026). MarketBeat listed a consensus target of $98.78 and 24 buy ratings against 8 holds and no sells in early October 2026.
• Upgrade and product news arrived in September. Wolfe Research upgraded the shares to Outperform with a $90 target on 14 September 2026, and Affirm reported a 3.4% lift in completed purchases against a control group from its new underwriting model on 17 September 2026. The lift is the company's own test result.

Bear case

• Price has not confirmed the upgrades. The close was $71.21 on 18 September 2026 and $70.43 on 1 October 2026, below the $72.35 close of 4 September 2026, despite Wolfe's upgrade and the target increases. The 3-month price change was -17.9%.
• Targets sit far above the price. The $98.78 MarketBeat consensus target is 40% above the last close, and UBS kept a Neutral rating with a $90 target on 28 August 2026. A gap that wide leaves room for targets to fall if guidance slips.
• Rate sensitivity. Benzinga reported on 28 August 2026 that the Nasdaq 100 fell as rate-hike odds rose. Higher funding costs weigh on lenders whose loans are financed in capital markets, and AFRM has moved with the consumer-lending group.
• The credit improvement is narrow. The 2.5% delinquency figure excludes Peloton and Pay-in-X loans. A reading above 2.8% on the same scope in the next disclosure would reverse the improvement.
• Guidance floors leave little margin. The prior note recorded first-quarter fiscal 2027 floors of $1.19 billion in revenue and $13.7 billion in GMV; the shares carry a growth premium that a miss on either would test.

Price setup

The last completed close was $70.43 on 1 October 2026. The 52-week high is $85.78, 17.9% above that close, and the 3-month change is -17.9%. RSI(14) is 47.7.

The prior note identified $69 as the weekly-close level at the reclaimed 200-day moving average and the mid-June recovery low. The price is 2.1% above it. The shares have drifted from $72.35 (4 September 2026 close) to $71.21 (18 September 2026) to $70.43 with no new high, while analyst coverage was added.

The crowding evidence is thin on the buying side: 32 of the ratings MarketBeat counted are buy or hold, and no sell ratings exist, so little incremental endorsement is left to arrive. No insider transactions or share issuance appeared in the supplied filings for the period. The next earnings date is outside 30 days, so no results event sits within the near-term window. MarketBeat showed 5 November 2026 as the expected date and another source showed 11 November 2026; the company had not confirmed either in the sources reviewed.

Catalysts, next 30 days

• 28 October 2026 (est.) — Federal Open Market Committee rate decision. The shares have traded with rate-hike expectations since late August.
• ~5 November 2026, est. — First-quarter fiscal 2027 results (a second source lists 11 November 2026). This falls just past the 30-day window but settles whether revenue and GMV meet the August guidance floors.
• No company-specific event is dated inside the next 30 days in the sources reviewed.

What would change the view

The case breaks if the shares close a week below $69, which would lose the reclaimed 200-day moving average and turn the recovery into a failed reclaim. It also breaks if the first-quarter fiscal 2027 report shows revenue below $1.19 billion or GMV below $13.7 billion, if the fiscal 2027 GMV guide of more than $64 billion is lowered, or if 30-day delinquency on the monthly installment scope rises above 2.8%.

The case strengthens if the report meets those floors and the shares close above the 4 September 2026 close of $72.35, which would show price following the estimate and target changes that have already occurred.

What it trades with

AFRM has traded with consumer-lending and rate-sensitive growth shares, per the October 2026 market coverage reviewed, and with the Nasdaq 100 on days when rate-hike odds move (Benzinga, 28 August 2026). A rise in the 2-year Treasury yield has been the main outside pressure named in coverage. Peers in consumer credit report on their own calendars, and delinquency or funding commentary from them can move AFRM before its own report.